Is lowering phosphate exposure the key to preventing arterial stiffening with age?

被引:24
作者
Ferro, C. J. [1 ]
Chue, C. D. [2 ]
Steeds, R. P. [3 ]
Townend, J. N. [3 ]
机构
[1] Univ Hosp Birmingham, Queen Elizabeth Hosp, NHS Fdn Trust, Dept Nephrol, Birmingham B15 2TH, W Midlands, England
[2] Univ Birmingham, Dept Cardiovasc Med, Birmingham, W Midlands, England
[3] Univ Hosp Birmingham, Queen Elizabeth Hosp, NHS Fdn Trust, Dept Cardiol, Birmingham B15 2TH, W Midlands, England
关键词
CHRONIC KIDNEY-DISEASE; VITAMIN-D; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; PARATHYROID-HORMONE; MINERAL METABOLISM; MORTALITY; CALCIUM; PHOSPHORUS; STIFFNESS;
D O I
10.1136/hrt.2008.162594
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Cardiovascular disease remains the leading cause of death world wide. Although atheroma is clearly important, the role of arteriosclerotic vascular disease is often overlooked. Arteriosclerosis causes increased arterial stiffness, with consequent systolic hypertension and left ventricular hypertrophy. Serum phosphate is increasingly being recognised as a cardiovascular risk factor and has been implicated in the development of arteriosclerosis and arterial calcification. Its determinants are unclear, but both diet and minor reductions in renal function may be important. Diets in affluent populations are high in phosphate because of increased consumption of animal protein and the use of phosphate-containing preservatives. This viewpoint suggests that the consumption of a phosphate-rich diet, exacerbated by the high prevalence of chronic kidney disease found in ageing populations, accelerates the development of arteriosclerosis. It is hypothesised that reducing phosphate intake will attenuate the progression of arterial stiffness with major beneficial effects upon cardiovascular mortality and morbidity.
引用
收藏
页码:1770 / 1772
页数:3
相关论文
共 30 条
[1]
AMANN K, 1994, J AM SOC NEPHROL, V4, P1814
[2]
Niacin and related compounds for treating hyperphosphatemia in dialysis patients [J].
Berns, Jeffrey S. .
SEMINARS IN DIALYSIS, 2008, 21 (03) :203-205
[3]
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[4]
Changing phosphorus content of the US diet: Potential for adverse effects on bone [J].
Calvo, MS ;
Park, YK .
JOURNAL OF NUTRITION, 1996, 126 (04) :S1168-S1180
[5]
Prevalence of chronic kidney disease in the United States [J].
Coresh, Josef ;
Selvin, Elizabeth ;
Stevens, Lesley A. ;
Manzi, Jane ;
Kusek, John W. ;
Eggers, Paul ;
Van Lente, Frederick ;
Levey, Andrew S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17) :2038-2047
[6]
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease [J].
Covic, Adrian ;
Kothawala, Prajesh ;
Bernal, Myriam ;
Robbins, Sean ;
Chalian, Arpi ;
Goldsmith, David .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (05) :1506-1523
[7]
What is the role of the aorta in directing coronary blood flow? [J].
Davies, Justin E. ;
Parker, Kim H. ;
Francis, Darrel P. ;
Hughes, Alun D. ;
Mayet, Jamil .
HEART, 2008, 94 (12) :1545-1547
[8]
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community [J].
Dhingra, Ravi ;
Sullivan, Lisa M. ;
Fox, Caroline S. ;
Wang, Thomas J. ;
D'Agostino, Ralph B. ;
Gaziano, J. Michael ;
Vasan, Ramachandran S. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (09) :879-885
[9]
Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction [J].
Edwards, N. C. ;
Ferro, C. J. ;
Townend, J. N. ;
Steeds, R. P. .
HEART, 2008, 94 (08) :1038-1043
[10]
Flegal KM, 1999, AM J CLIN NUTR, V69, p1339S